Literature DB >> 28515613

Secondary Sjogren's Syndrome Presenting with Distal Tubular Acidosis and Quadriparesis.

Kartik Munta1, Manimala Rao Surath1, K Seshikiran1.   

Abstract

A 52-year-old female patient was admitted to Intensive Care Unit with complaints of quadriparesis. Investigations revealed distal renal tubular acidosis (DRTA) secondary to Sjogren's syndrome with involvement of the parotid and thyroid glands. Laboratory investigations showed hyperchloremic metabolic acidosis and an alkaline urine pH with clinical signs of sicca syndrome. Sjogren's syndrome is associated with DRTA and occurrences of quadriparetic hypokalemia, nephrolithiasis, and osteomalacia can be prevented with early diagnosis and lifelong treatment with potassium and alkali replacement.

Entities:  

Keywords:  Distal renal tubular acidosis; Hashimoto's thyroiditis; Sjogren's syndrome; hypokalemia

Year:  2017        PMID: 28515613      PMCID: PMC5416796          DOI: 10.4103/ijccm.IJCCM_442_16

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


INTRODUCTION

Acute quadriparesis is seen commonly caused by severe hypokalemia. The cause of the severe hypokalemia usually may be drug induced, nutritional deficiency, or due to potassium wasting in renal tubular acidosis. The treatment involves correction of hypokalemia and diagnosing the precipitating causes of the hypokalemia. This case report intends to highlight the chances of an autoimmune disorder, such as Sjogren's syndrome as a causative etiology.

CASE REPORT

A 52-year-old female was admitted with complaints of quadriparesis and slurring of speech for 2 days. She was a known hypertensive and was on treatment with beta-blockers. Her history was not suggestive of any medications or conditions which could have caused severe hypokalemia. At presentation, she was normotensive with a heart rate of 60/min and electrocardiography changes suggestive of hypokalemia with U-waves [Figure 1]. Laboratory results showed severe hypokalemia (1.5 meq/L) and arterial blood gases revealed picture of metabolic acidosis with pH 7.22 and serum bicarbonate 15.2 mmol/L. Laboratory data showed serum chloride 111.3 meq/L, magnesium 2.65 meq/L, albumin 3.80, globulin 3.90, and an anion gap of 14. Further workup revealed urine pH 5.7, a normal 24 h urinary potassium concentration of 40.36 mmol/day, raised 24 h urinary calcium of 487 mg/day, and normal serum cortisol.
Figure 1

Electrocardiography showing characteristic U-waves seen in hypokalemia

Electrocardiography showing characteristic U-waves seen in hypokalemia Hypokalemia was corrected by potassium supplementation with monitoring of serum potassium 12 hourly. Thyroid profile showed hypothyroidism with elevated thyroid-stimulating hormone and thyroid antibodies level of 28.9 meq/L, suggesting an autoimmune thyroid disorder. An autoimmune antibody profile was sent to investigate the cause of distal renal tubular acidosis (DRTA) and it showed positive antinuclear antibody (ANA) of 1:80 and strong positive for SS-A, Ro-52 and mild positive for Ds-DNA. Further investigation into patient's history and clinical examination revealed complaints of dry eyes and mouth in the past and parotid swellings bilaterally. Biopsy of parotid could not be done due to refusal of consent by the patient. Based on the ANA profile, clinical history, parotid involvement, metabolic acidosis with severe hypokalemia, and autoimmune thyroiditis, a diagnosis of Sjogren's syndrome causing DRTA with autoimmune thyroiditis was made. The patient responded well to the treatment with correction of potassium and supplementation of intravenous bicarbonate, showing marked improvement of weakness and speech.

DISCUSSION

Sjogren's syndrome is known to manifest through symptoms such as dry eyes and mouth. Renal involvement in Sjogren's syndrome is seen ranging from 4.2% to 50%.[1] DRTA occurs due to an abnormality in renal acidification in the distal renal tubules, thereby leading to alkaline urine and hypokalemia. However, the occurrence of hypokalemic paralysis due to DRTA secondary to Sjogren's happens rarely. Literature search has revealed only 18 cases between 1966 and 2004.[2] The cause of DRTA in Sjogren's syndrome is not clearly understood. High levels of anticarbonic anhydrase antibodies affecting the functioning of carbonic anhydrase in collecting ducts and acidification defect due to lack of intact H+ATPase pumps in intercalated cells have been found in such occurrences.[34] Typically, patients present with hyperchloremia, metabolic acidosis, alkaline urine, renal hypercalciuria, and severe hypokalemia as it was seen in our case. Secondary causes of DRTA include chronic active hepatitis, systemic lupus erythematosus, hypergammaglobulinemia, and Sjogren's syndrome. The autoimmune workup in our case revealed strong positive SSA and Ro-52 and mild positive Ds-DNA with clinical signs of parotid enlargement, xerostomia, and dry eyes which were helpful in diagnosing Sjogren's syndrome. Sjogren's syndrome has been shown to occur more in the 40–45 years age group with a female predominance of 10:1.[5] The frequency of occurrence of Hashimoto's thyroiditis is higher in Sjogren's syndrome patients and is seen in 6.26% as opposed to 1%–2% in normal population. In addition, 35% of thyroid disorder patients manifest sicca features making it difficult to determine whether a patient has primary Sjogren's syndrome or autoimmune thyroiditis.[6]

CONCLUSION

Patients presenting with severe hypokalemia causing muscular weakness should be worked up for a DRTA. This can be diagnosed with classic findings of metabolic acidosis, alkaline urine, normal anion gap, and positive urinary anion gap with hypokalemia. While assessing for causes of DRTA occurrence in females of middle age, causative factors such as autoimmune disorders should also be investigated.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Clinical and morphological features of kidney involvement in primary Sjögren's syndrome.

Authors:  N Bossini; S Savoldi; F Franceschini; S Mombelloni; M Baronio; I Cavazzana; B F Viola; B Valzorio; C Mazzucchelli; R Cattaneo; F Scolari; R Maiorca
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

2.  Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome.

Authors:  Fumi Takemoto; Junichi Hoshino; Naoki Sawa; Yoshifuru Tamura; Tetsuo Tagami; Masafumi Yokota; Hideyuki Katori; Keitaro Yokoyama; Yoshifumi Ubara; Shigeko Hara; Kenmei Takaichi; Akira Yamada; Shunya Uchida
Journal:  Am J Med       Date:  2005-02       Impact factor: 4.965

3.  Absence of H(+)-ATPase in the intercalated cells of renal tissues in classic distal renal tubular acidosis.

Authors:  K W Joo; U S Jeon; J S Han; C Ahn; S Kim; J S Lee; G H Kim; Y S Cho; Y H Kim; J Kim
Journal:  Clin Nephrol       Date:  1998-04       Impact factor: 0.975

4.  Primary Sjögren's syndrome from the viewpoint of an internal physician.

Authors:  G Pokorny; J Németh; I Marczinovits; M Kiss; J Hudák; S Husz
Journal:  Int Ophthalmol       Date:  1991-11       Impact factor: 2.031

5.  A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.

Authors:  Mehmet Soy; Omer Nuri Pamuk; Murat Gerenli; Yahya Celik
Journal:  Rheumatol Int       Date:  2005-02-03       Impact factor: 2.631

6.  Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome.

Authors:  Margit Zeher; Ildiko Fanny Horvath; Antonia Szanto; Peter Szodoray
Journal:  Thyroid       Date:  2009-01       Impact factor: 6.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.